Inotiv
NOTV
#10058
Rank
โ‚ฌ24.49 M
Marketcap
0,71ย โ‚ฌ
Share price
2.76%
Change (1 day)
-80.78%
Change (1 year)

Revenue for Inotiv (NOTV)

Revenue in 2025 (TTM): โ‚ฌ0.45 Billion

According to Inotiv's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.43 Billion. In 2024 the company made a revenue of โ‚ฌ0.45 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inotiv from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.45 B0.33%
2024 โ‚ฌ0.45 B-13.75%
2023 โ‚ฌ0.52 B-3.14%
2022 โ‚ฌ0.54 B296.91%
2021 โ‚ฌ0.13 B158.81%
2020 โ‚ฌ53.2 M24.4%
2019 โ‚ฌ42.76 M65.32%
2018 โ‚ฌ25.86 M32.39%
2017 โ‚ฌ19.53 M-5.37%
2016 โ‚ฌ20.64 M3.82%
2015 โ‚ฌ19.89 M-0.08%
2014 โ‚ฌ19.9 M22.26%
2013 โ‚ฌ16.28 M-18.72%
2012 โ‚ฌ20.02 M-20.14%
2011 โ‚ฌ25.07 M9.4%
2010 โ‚ฌ22.92 M9.18%
2009 โ‚ฌ20.99 M-26.5%
2008 โ‚ฌ28.56 M-5.33%
2007 โ‚ฌ30.17 M-9.68%
2006 โ‚ฌ33.41 M-6.97%
2005 โ‚ฌ35.91 M27.98%
2004 โ‚ฌ28.06 M11.66%
2003 โ‚ฌ25.13 M-4.34%
2002 โ‚ฌ26.27 M-10.32%
2001 โ‚ฌ29.29 M36.59%
2000 โ‚ฌ21.44 M9.38%
1999 โ‚ฌ19.6 M25.77%
1998 โ‚ฌ15.58 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚ฌ0.11 B-72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas